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article [1]. It refers to the controversies that have arisen over
the years in this ﬁeld. We believe that some issues concerning
our study need further clariﬁcation. The ﬁrst concerns the role
that Chlamydia and cytomegalovirus play in the development of
atherosclerosis. We agree that there much evidence, but it
should be noted that this evidence is far from conclusive. In fact,
there is no unanimity in the observational studies [2], and the
results of intervention studies have been disappointing [3]. Our
results with respect to these two microorganisms follow this
line, especially when compared to those performed in an
elderly population [2]. The sample size (although calculated for
Coxiella) was appropriate for Chlamydia and the seroprevalence
was expected; the results are thus valid and reproducible.
However, the same cannot be said for cytomegalovirus. The
high prevalence prevented us from performing of a multivariate
analysis, which would have required a much larger number of
patients. However, this limitation was discussed in the text, and
it does not alter the main conclusion of the study.
Regarding controversies arising regarding the methodology,
we believe that a careful reading would resolve most of them.
Brieﬂy, American College of Cardiology criteria were utilized
to deﬁne and classify the atherosclerotic cardiovascular disease
[4]. This classiﬁcation was part of the study procedures, but
secondary data were not forgotten. Our hospital receives and
supervises almost all cardiovascular pathology occurring in its
area of inﬂuence, and access to complete and uniﬁedMicrobiol Infect 2015; 21: e30–e31
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tient with hip fracture and a history of stroke. In this case, a
new brain scan may not be necessary in the presence of a
previously performed scan. Finally, the cardiovascular specialist
was not the patient’s physician but was the one who supervised
the diagnosis and classiﬁcation of cases.
On the other hand, although imaging techniques are helpful,
they are not essential for the diagnosis and classiﬁcation of
cardiovascular disease [4]. This can also be seen best by
example. Taking the above case, the presence of typical
symptoms of intermittent claudication, absence or weakness of
distal pulses and murmur at the femoral level are sufﬁcient to
diagnose atherosclerotic peripheral artery disease in the
absence of conﬁrmatory vascular imaging. However, the same
cannot be said with regard to cerebrovascular disease, where
the absence of a scan or magnetic resonance imaging could
seriously compromise a correct diagnosis and classiﬁcation. All
the strokes, and 93% of coronary heart disease and peripheral
artery disease, had imaging performed at some point in their
illness.
The authors of the letter suggest that the multivariate model
should include a larger number of control variables as a result
of the heterogeneity of the groups. It is good that the sample
was heterogeneous, as it increases their representativeness,
decreases bias and gives more credibility to the results. We
agree with the author on the need to control for confounding
factors, so the odds ratio was adjusted for age, sex, hyperten-
sion, diabetes, dyslipidaemia, atrial ﬁbrillation/atrial ﬂutter
(sustained or paroxysmal) and smoking—that is, the main risk
factors involved in the development of atherosclerotic cardio-
vascular and cerebrovascular disease. In our research, both
primary (including direct patient or family survey) and sec-
ondary data were used. As was discussed in the text, neither
C-reactive protein level nor age was included in the regression
analysis. The former was not included because it was similar in
both groups, and the latter was not included because it was a
variable subject to control. In addition, C-reactive protein is not
a conﬁrmed cardiovascular risk factor and is subject to a wide
variation in the presence of acute intercurrent processes.
The proposal of Chatzidimitriou et al. to perform a subgroup
analysis is interesting, but this was not viable in our sample
because it was not an initial aim of the study, and therefore it
was not taken into account when we calculated the sample size.
Other studies focused on speciﬁc subgroups of cardiovascular
disease should be considered in the future for this purpose.
Lastly, Chatzidimitriou et al. argue that the cross-sectional
nature of the present study limits its clinical usefulness, and
they suggest that Coxiella burnetii being “innocent bystanders”
is the most likely hypothesis. We agree with the ﬁrstious Diseases. Published by Elsevier Ltd. All rights reserved
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could never establish a causal link and therefore should not
have clinical implications. Case–control studies can generate
associations but not risk factors. At the same time, associa-
tions must, and can, generate hypotheses, and the authors of
the letter are inclined to be the ones who consider Coxiella to
be “innocent bystanders.” However, the bulk of the evidence
points in the opposite direction. C. burnetii, as discussed in the
text, is an intracellular microorganism able to persist in the
body, can be reactivated and cause systemic and local com-
plications, many of them related to previously damaged heart
valves and vascular beds [5]. It is in this context where this
association arises, and it is in this context where it should be
interpreted.
In conclusion, our study has opened a new line of research,
but others must conﬁrm our results, expand our knowledge
and attempt to resolve the many controversies that have arisen
around this fascinating association.Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyReferences[1] González-Quijada S, Mora-Simón MJ, Martin-Ezquerro A. Association
between serological evidence of past Coxiella burnetii infection and
atherosclerotic cardiovascular disease in elderly patients. Clin Microbiol
Infect 2014;20:873–8.
[2] Ngeh J, Gupta S, Goodbourn C, Panayiotou B, McElligott G. Chlamydia
pneumoniae in elderly patients with stroke (C-PEPS): a case–control
study on the seroprevalence of Chlamydia pneumoniae in elderly patients
with acute cerebrovascular disease. Cerebrovasc Dis 2003;15:11–6.
[3] Wells BJ, Mainous 3rd AG, Dickerson LM. Antibiotics for the secondary
prevention of ischemic heart disease: a meta-analysis of randomized
controlled trials. Arch Intern Med 2004;164:2156–61.
[4] Laslett LJ, Alagona P, Clark BA, Drozda JP, Saldivar F, Wilson SR, et al.
The worldwide environment of cardiovascular disease: prevalence,
diagnosis, therapy, and policy issues: a report from the American Col-
lege of Cardiology. J Am Coll Cardiol 2012:60–7.
[5] Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE,
Bernit E, et al. Q fever 1985–1998. Clinical and epidemiologic features
of 1,383 infections. Medicine (Baltimore) 2000;79:109–23.and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21 e30–e31
